1. Stocks
  2. Dr. Lal Pathlabs Ltd.
  3. Swot
swot-logo

Dr. Lal Pathlabs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Dr. Lal Pathlabs Ltd. has 12 Strengths, 7 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Month

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

Top Losers

Mutual Funds Increased Shareholding in Past Month

Highest FII stock holdings

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Insiders sold stocks

High Piotroski Score - Companies with strong financials

Rising Delivery Percentage Compared to Prev Day

Big Changes up or down in FII holding

Expensive Performers (DVM)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)